Research
Semaglutide may improve eating disorder symptoms and body image in adults seeking obesity treatment
The Brief
- A study reports that adults receiving semaglutide for obesity showed greater improvements than placebo on several measures of disordered eating, eating disorder symptoms and body image concerns.
- The findings come from a new study led by researchers whose affiliation is cut off in the available source excerpt.
- Source details are limited to a single news summary dated 2026-11-18.
Why it matters
Semaglutide is widely prescribed for obesity, so evidence on its effects on eating behaviour and body image bears on how clinicians and researchers think about treatment outcomes beyond weight.
Who’s affected
- clinicians treating adults with obesity
- researchers studying eating disorders and obesity pharmacotherapy
- #semaglutide
- #obesity
- #eating disorders
- #body image
- #clinical research
Adults receiving semaglutide for obesity treatment experienced greater improvements in several measures of disordered eating, eating disorder symptoms and body image concerns compared with participants receiving placebo, according to a new study led by researchers from the…